Found 18 hits for monomerid = 427905 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kcal/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10544143 (2020)
BindingDB Entry DOI: 10.7270/Q2QF8W80 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.87E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 5.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10544143 (2020)
BindingDB Entry DOI: 10.7270/Q2QF8W80 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10544143 (2020)
BindingDB Entry DOI: 10.7270/Q2QF8W80 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 51 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10544143 (2020)
BindingDB Entry DOI: 10.7270/Q2QF8W80 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.87E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10544143 (2020)
BindingDB Entry DOI: 10.7270/Q2QF8W80 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 7.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 5.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 51 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.87E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10730877 (2020)
BindingDB Entry DOI: 10.7270/Q2H41VH3 |
More data for this
Ligand-Target Pair | |
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 7.10 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 9
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 5.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 7
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 51 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
HEK-Blue™-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducibl... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2S46W4Z |
More data for this
Ligand-Target Pair | |
Toll-like receptor 8
(Homo sapiens (Human)) | BDBM427905
(US10544143, Example 339 | US10544143, Example 340 ...)Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)N(C)CCC#N |(8.87,1.21,;7.33,1.21,;6.56,-.12,;5.02,-.12,;4.25,-1.46,;5.02,-2.79,;6.56,-2.79,;7.59,-3.93,;9,-3.31,;8.84,-1.78,;7.33,-1.46,;2.71,-1.46,;1.8,-2.7,;.34,-2.23,;-.99,-3,;-2.33,-2.23,;-3.66,-3,;-2.33,-.69,;-.99,.08,;.34,-.69,;1.8,-.21,;2.2,1.28,;1.11,2.37,;3.69,1.68,;-3.66,.08,;-5,-.69,;-6.33,.08,;-6.33,1.62,;-5,2.39,;-3.66,1.62,;-7.66,2.39,;-7.66,3.93,;-9,1.62,;-10.33,2.39,;-11.66,1.62,;-13,.85,)| Show InChI InChI=1S/C28H35N7O/c1-17(2)24-26(20-14-23(36-5)28-30-16-31-35(28)15-20)32-22-13-18(3)25(33-27(22)24)19-7-9-21(10-8-19)34(4)12-6-11-29/h13-17,19,21,32H,6-10,12H2,1-5H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 7.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
US Patent
| Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible... |
US Patent US10544143 (2020)
BindingDB Entry DOI: 10.7270/Q2QF8W80 |
More data for this
Ligand-Target Pair | |
Search and Browse
